Rapt Therapeutics

Youtube Subscribe

Open: 19.03 Close: 17.57 Change: -1.46

Is Rapt Therapeutics Company Inc a good investment? This what an AI found.

Are looking for the most relevant information about Rapt Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Rapt Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Rapt Therapeutics are: RAPT, Therapeutics, price, target, Rapt, upside, mean, and the most common words in the summary are: start, therapeutic, date20070516, share, pharmaceutical, holding, class, . One of the sentences in the summary was: The average price target of Wall Street analysts set by Wall …

Concept Map

Semantic Network

Stock Summary

RAPT Therapeutics, Inc. focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. Its lead inflammation drug candidate is.

Today's Summary

RAPT Therapeutics stock opened at $18.20 on Monday. Cantor Fitzgerald lowered their target price on shares of RAPTT from $44.00 to $40.00. The average price target of Wall Street analysts set by Wall Street indicates a potential upside.

Today's News

RAPT Therapeutics Inc. (RAPT) Price Target $42.0 (139.04% upside) Analyst Consensus: Strong Buy Stock Forecasts. Pomerantz LLP is investigating claims on behalf of investors. The mean of analysts price targets for Rapt Therapeutics (RAPT) points to a 122.4% upside in the stock. The mean price target hints at an 115.5% upside potential for Rapt. The average price target of Wall Street analysts set by Wall Street indicates a potential upside of 74% in Rapt Therapesur. Rapt Therapies (RapT) currently stands at an ai firm Chesterllo Hew basketballbranded eld Supreme490 beats 83 response republic RAPT Therapeutics stock opened at $18.20 on Monday. Cantor Fitzgerald lowered their target price on shares of RAPTT from $44.00 to $40.00 in a research note on Wednesday, March 15th. HC Wainwright reaffirmed a “buy” rating and issued a $43. RAPT Therapeutics is a clinical stage immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. The company will present a poster on FLX475 at the 2023 American Society of Clinical Oncology (ASCO) annual meeting.

Stock Profile

"RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California."

Keywords

The game is changing. There is a new strategy to evaluate Rapt Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Rapt Therapeutics are: RAPT, Therapeutics, price, target, Rapt, upside, mean, and the most common words in the summary are: start, therapeutic, date20070516, share, pharmaceutical, holding, class, . One of the sentences in the summary was: The average price target of Wall Street analysts set by Wall Street indicates a potential upside.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #start #therapeutic #date20070516 #share #pharmaceutical #holding #class.

Read more →

Youtube Subscribe

---